These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1100888)

  • 1. Observations on nonconverting phage, c-n71, obtained from a nontoxigenic strain of Clostridium botulinum type C.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1975 Jun; 19(3):167-72. PubMed ID: 1100888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D.
    Fujii N; Oguma K; Yokosawa N; Kimura K; Tsuzuki K
    Appl Environ Microbiol; 1988 Jan; 54(1):69-73. PubMed ID: 3278690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity.
    Hariharan H; Mitchell WR
    Appl Environ Microbiol; 1976 Jul; 32(1):145-58. PubMed ID: 61735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage and the toxigenicity of Clostridium botulinum type C.
    Eklund MW; Poysky FT; Reed SM; Smith CA
    Science; 1971 Apr; 172(3982):480-2. PubMed ID: 4927679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Infect Immun; 1976 Sep; 14(3):597-602. PubMed ID: 786888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of nontoxigenic variants associated with enhanced sporulation and alteration in the cell wall from Clostridium botulinum type a 190L by treatment with detergents.
    Takumi K; Kinouchi T; Kawata T
    Microbiol Immunol; 1980; 24(6):469-77. PubMed ID: 6997693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two inducible bacteriophages, alpha 1 and alpha 2, isolated from Clostridium botulinum type A 190L and their deoxyribonucleic acids.
    Kinouchi T; Takumi K; Kawata T
    Microbiol Immunol; 1981; 25(9):915-27. PubMed ID: 6273702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
    Zhou Y; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrachromosomal genetic elements of Clostridium botulinum. II. Isolation and analysis of DNA from bacteriophages of Clostridium botulinum types C and A].
    Rudoĭ BA; Telitsyn AM; Bakulina LV; Evstigneev VI
    Mol Gen Mikrobiol Virusol; 1998; (4):22-8. PubMed ID: 9987749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation on non-converting phage; C-N 71 (author's transl)].
    Oguma K
    Hokkaido Igaku Zasshi; 1974 Mar; 49(2):137-41. PubMed ID: 4615995
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.
    Suzuki T; Nagano T; Niwa K; Uchino M; Tomizawa M; Sagane Y; Watanabe T
    Curr Microbiol; 2017 Jan; 74(1):49-54. PubMed ID: 27785552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of structural genes for Clostridium botulinum type C neurotoxin-converting phage particles.
    Hwang HJ; Lee JC; Yamamoto Y; Sarker MR; Tsuchiya T; Oguma K
    FEMS Microbiol Lett; 2007 May; 270(1):82-9. PubMed ID: 17302935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K; Iida H
    Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani.
    Hara T; Matsuda M; Yoneda M
    Biken J; 1977 Dec; 20(3-4):105-15. PubMed ID: 352338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phage conversion of toxigenicity in Clostridium botulinum].
    Khotenko SG; Perova EV; Golikov VI; Bulatova TI; Il'iashenko BN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):25-8. PubMed ID: 7004020
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriophages of Clostridium botulinum types A, B, E, and F and nontoxigenic strains resembling type E.
    Eklund MW; Poysky FT; Boatman ES
    J Virol; 1969 Feb; 3(2):270-4. PubMed ID: 4886656
    [No Abstract]   [Full Text] [Related]  

  • 19. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boticinogeny and actions of the bacteriocin.
    Anastasio KL; Soucheck JA; Sugiyama H
    J Bacteriol; 1971 Jul; 107(1):143-9. PubMed ID: 4935316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.